Related Experiment Video
Updated: May 25, 2026
09:12
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
LRRK2 inhibition attenuates microglial inflammatory responses.
Mark S Moehle1, Philip J Webber, Tonia Tse
1Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
Summary
Leucine-rich repeat kinase 2 (LRRK2) regulates microglial inflammatory responses and morphology in the brain. Inhibiting LRRK2 kinase activity reduces pro-inflammatory mediators and affects microglial cell shape and movement.
Area of Science:
- Neuroimmunology
- Molecular Neuroscience
- Genetics of Neurodegenerative Diseases
Background:
- Missense mutations in leucine-rich repeat kinase 2 (LRRK2) are a known cause of late-onset Parkinson's disease (PD).
- LRRK2 is expressed in peripheral immune cells, but its role in brain-resident immune cells, like microglia, is largely unknown.
- Microglia are key immune cells in the brain implicated in neuroinflammation and neurodegenerative conditions.
Purpose of the Study:
- To investigate the role and regulation of LRRK2 in microglial inflammatory responses and morphology.
- To determine if LRRK2 kinase activity influences pro-inflammatory mediator release and cytoskeletal dynamics in microglia.
- To explore the potential involvement of LRRK2 in the pathogenesis of Parkinson's disease.
Main Methods:
- Utilized a murine model of neuroinflammation to observe LRRK2 induction in microglia.
- Employed toll-like receptor 4 (TLR4) stimulation in primary rat microglia to study LRRK2 activity and expression.
- Applied LRRK2 kinase inhibitors and protein knockdown, alongside actin inhibitors, to assess functional outcomes.
Main Results:
- Observed robust induction of LRRK2 in microglia during neuroinflammation.
- Demonstrated that TLR4 stimulation increases LRRK2 activity and expression in microglia.
- Showed that LRRK2 inhibition attenuates TNFα secretion and nitric oxide synthase (iNOS) induction.
- Found that LRRK2 inhibition impairs microglial process outgrowth and chemotaxis, acting upstream of cytoskeletal regulation.
Conclusions:
- LRRK2 plays a significant role in regulating microglial pro-inflammatory responses and morphological changes.
- LRRK2 functions as a stress-responsive kinase in microglia, influencing their activation and function.
- These findings highlight LRRK2's involvement in brain immune cell responses and implicate microglia in the pathophysiology of late-onset Parkinson's disease.